Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Integra Lifesciences Holdings (IART) Gross Profit (2016 - 2026)

Integra Lifesciences Holdings' Gross Profit history spans 17 years, with the latest figure at $220.9 million for Q4 2025.

  • On a quarterly basis, Gross Profit fell 11.32% to $220.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $831.6 million, a 5.72% decrease, with the full-year FY2025 number at $831.6 million, down 5.72% from a year prior.
  • Gross Profit hit $220.9 million in Q4 2025 for Integra Lifesciences Holdings, up from $207.0 million in the prior quarter.
  • Over the last five years, Gross Profit for IART hit a ceiling of $250.1 million in Q4 2022 and a floor of $194.4 million in Q1 2025.
  • Historically, Gross Profit has averaged $225.7 million across 5 years, with a median of $226.2 million in 2023.
  • Biggest five-year swings in Gross Profit: soared 55.84% in 2021 and later decreased 16.99% in 2023.
  • Tracing IART's Gross Profit over 5 years: stood at $249.3 million in 2021, then rose by 0.33% to $250.1 million in 2022, then decreased by 9.43% to $226.5 million in 2023, then grew by 9.97% to $249.1 million in 2024, then decreased by 11.32% to $220.9 million in 2025.
  • Business Quant data shows Gross Profit for IART at $220.9 million in Q4 2025, $207.0 million in Q3 2025, and $209.3 million in Q2 2025.